Three Way Crossover Closed Loop Study With Xeris Glucagon

clinical trial

MedicalStudy clinical_trial Q63402290

Press Enter · cited answer in seconds

Three Way Crossover Closed Loop Study With Xeris Glucagon

Summary

Three Way Crossover Closed Loop Study With Xeris Glucagon is a clinical trial^[1].

Key Facts

Three Way Crossover Closed Loop Study With Xeris Glucagon is in the country of United States^[2].
Three Way Crossover Closed Loop Study With Xeris Glucagon's instance of is recorded as clinical trial^[3].
Three Way Crossover Closed Loop Study With Xeris Glucagon's start time is recorded as +2018-03-29T00:00:00Z^[4].
Three Way Crossover Closed Loop Study With Xeris Glucagon's end time is recorded as +2019-05-30T00:00:00Z^[5].
Three Way Crossover Closed Loop Study With Xeris Glucagon's sponsor is recorded as Oregon Health and Science University^[6].
Three Way Crossover Closed Loop Study With Xeris Glucagon's main subject is recorded as physical exercise^[7].
Three Way Crossover Closed Loop Study With Xeris Glucagon's number of participants is recorded as {'unit': '1', 'amount': '+23'}^[8].
Three Way Crossover Closed Loop Study With Xeris Glucagon's title is recorded as A Randomized, Three-way, Cross-over Study to Assess the Efficacy of a Dual-hormone Closed-loop System With XeriSol™ Glucagon vs Closed-loop System With Insulin Only vs a Predictive Low Glucose Suspend System^[9].
Three Way Crossover Closed Loop Study With Xeris Glucagon's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+21'}^[10].
Three Way Crossover Closed Loop Study With Xeris Glucagon's ClinicalTrials.gov ID is recorded as NCT03424044^[11].
Three Way Crossover Closed Loop Study With Xeris Glucagon's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}^[12].
Three Way Crossover Closed Loop Study With Xeris Glucagon's research intervention is recorded as glucagon^[13].
Three Way Crossover Closed Loop Study With Xeris Glucagon's research intervention is recorded as glucagon-like peptide-1^[14].
Three Way Crossover Closed Loop Study With Xeris Glucagon's research intervention is recorded as pancrelipase^[15].
Three Way Crossover Closed Loop Study With Xeris Glucagon's clinical trial phase is recorded as phase I clinical trial^[16].
Three Way Crossover Closed Loop Study With Xeris Glucagon's research site is recorded as Oregon Health and Science University^[17].
Three Way Crossover Closed Loop Study With Xeris Glucagon's study type is recorded as interventional study^[18].

⭐ Popularity Graph

0/100 long tail

⛏️ Lake Facts · open-dataset statements via 4ort-mint

From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.

End timeP582

2019-05-17 2026-09-26 Wikidata lists 2019-05-30 ClinicalTrials.gov (US Government Public Domain)

ClinicalTrials.gov (data processed by ClinicalTrials.gov on 2026-09-26); U.S. federal government data, public domain; lake licence_code custom-review

Quick Facts

Instance of clinical trial

Country United States

Properties

Clinical trial phase phase I clinical trial

End time May 30, 2019

Imported from wholeness_audit_2026-05-02

Main subject physical exercise

Maximum age unit: www.wikidata.org, amount: +50

Minimum age unit: www.wikidata.org, amount: +21

Number of participants unit: 1, amount: +23

Research intervention glucagon, glucagon-like peptide-1, pancrelipase

Research site Oregon Health and Science University

Sponsor Oregon Health and Science University

Start time March 29, 2018

Study type interventional study

Title A Randomized, Three-way, Cross-over Study to Assess the Efficacy of a Dual-hormone Closed-loop System With XeriSol™ Glucagon vs Closed-loop System With Insulin Only vs a Predictive Low Glucose Suspend System

External References (1)

Clinicaltrials.gov id NCT03424044

🏷️ Also known as

en Three Way Crossover Closed Loop Study With Xeris Glucagon

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

Class ancestry

[1] ↑ Three Way Crossover Closed Loop Study With Xeris Glucagon is an instance of clinical trial (Q30612) [P31, primary]. Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA

4ort.xyz Knowledge Graph. (2026). Three Way Crossover Closed Loop Study With Xeris Glucagon. Retrieved May 3, 2026, from https://4ort.xyz/entity/three-way-crossover-closed-loop-study-with-xeris-glucagon

MLA

“Three Way Crossover Closed Loop Study With Xeris Glucagon.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/three-way-crossover-closed-loop-study-with-xeris-glucagon.

BibTeX

@misc{4ortxyz_three-way-crossover-closed-loop-study-with-xeris-glucagon_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Three Way Crossover Closed Loop Study With Xeris Glucagon}}, year = {2026}, url = {https://4ort.xyz/entity/three-way-crossover-closed-loop-study-with-xeris-glucagon}, note = {Accessed: 2026-05-03}}

LLM prompt

According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Three Way Crossover Closed Loop Study With Xeris Glucagon — https://4ort.xyz/entity/three-way-crossover-closed-loop-study-with-xeris-glucagon (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/three-way-crossover-closed-loop-study-with-xeris-glucagon · Last refreshed: May 3, 2026